• Oct 07, 2013 | Webcast

    Up and Coming Treatments for Bone Disease

    Michael Econs, MD; John Eisman, MBBS, PhD; Michael Whyte, MD; Seiji Fukumoto, MD, PhD; Bente Langdahl, MD, DMSc
    Investigation of Metabolic Bone Diseases, Rare Bone Diseases

    Chairs:
    Michael Econs, M.D.
    Indiana University School of Medicine, USA

    John Eisman, MBBS, Ph.D.
    Garvan Institute of Medical Research, Australia

    Speakers:
    Hypophosphatasia: Bone-Targeted Enzyme-Replacement Therapy
    Michael Whyte, M.D.
    Shriners Hospital for Children-Saint Louis, USA

    Prospects for FGF-23 Antibody Therapy
    Seiji Fukumoto, M.D., Ph.D.
    University of Tokyo Hospital, Japan

    Osteoporosis, Cathepsin K Enzyme Inhibition
    Bente Langdahl, M.D., DMSc
    Aarhus University Hospital, Denmark

    Supported by educational grants from Lilly USA, LLC and Merck & Co., Inc.

    Length: 75 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details